51 related articles for article (PubMed ID: 33525984)
1. Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer.
Purawarga Matada GS; Dhiwar PS; Abbas N; Singh E; Ghara A; Das A; Bhargava SV
J Biomol Struct Dyn; 2022 Aug; 40(13):6183-6192. PubMed ID: 33525984
[TBL] [Abstract][Full Text] [Related]
2. Structure Based docking studies towards exploring potential anti-androgen activity of selected phytochemicals against Prostate Cancer.
Singh AN; Baruah MM; Sharma N
Sci Rep; 2017 May; 7(1):1955. PubMed ID: 28512306
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi receptor approach for potential therapeutic agents in colorectal cancer.
Stany B; Mishra S; Rao KVB
Med Oncol; 2024 May; 41(6):156. PubMed ID: 38750377
[TBL] [Abstract][Full Text] [Related]
4.
Naik HN; Kanjariya D; Parveen S; Meena A; Ahmad I; Patel H; Meena R; Jauhari S
J Biomol Struct Dyn; 2024 Jul; 42(10):5415-5427. PubMed ID: 37394798
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoinformatics approach for the screening of Kovidra
More-Adate P; Lokhande KB; Shrivastava A; Doiphode S; Nagar S; Singh A; Baheti A
J Biomol Struct Dyn; 2024 May; 42(8):4263-4282. PubMed ID: 37288734
[TBL] [Abstract][Full Text] [Related]
6. Structure-based virtual screening of anti-breast cancer compounds from
Gnanaselvan S; Yadav SA; Manoharan SP
J Biomol Struct Dyn; 2024 Apr; 42(6):3267-3285. PubMed ID: 37194295
[TBL] [Abstract][Full Text] [Related]
7. Screening of phytochemicals from
Yasmeen N; Ahmad Chaudhary A; K Niraj RR; Lakhawat SS; Sharma PK; Kumar V
J Biomol Struct Dyn; 2023 Dec; ():1-43. PubMed ID: 38141177
[TBL] [Abstract][Full Text] [Related]
8. Dual functionality of pyrimidine and flavone in targeting genomic variants of EGFR and ER receptors to influence the differential survival rates in breast cancer patients.
Avti PK; Singh J; Dahiya D; Khanduja KL
Integr Biol (Camb); 2023 Apr; 15():. PubMed ID: 38084900
[TBL] [Abstract][Full Text] [Related]
9. Molecular modelling, docking and network analysis of phytochemicals from Haritaki churna: role of protein cross-talks for their action.
Khan MRUZ; Trivedi V
J Biomol Struct Dyn; 2024 May; 42(8):4297-4312. PubMed ID: 37288779
[TBL] [Abstract][Full Text] [Related]
10. Molecular recognition of bio-active triterpenoids from
Moharana M; Pattanayak SK; Khan F
J Biomol Struct Dyn; 2023; 41(24):14651-14664. PubMed ID: 36856037
[TBL] [Abstract][Full Text] [Related]
11. Structure Based Multitargeted Molecular Docking Analysis of Selected Furanocoumarins against Breast Cancer.
Acharya R; Chacko S; Bose P; Lapenna A; Pattanayak SP
Sci Rep; 2019 Oct; 9(1):15743. PubMed ID: 31673107
[TBL] [Abstract][Full Text] [Related]
12. Analysing potent biomarkers along phytochemicals for breast cancer therapy: an in silico approach.
Shekar N; Vuong P; Kaur P
Breast Cancer Res Treat; 2024 Jan; 203(1):29-47. PubMed ID: 37726449
[TBL] [Abstract][Full Text] [Related]
13.
Parvizpour S; Elengoe A; Alizadeh E; Razmara J; Shamsir MS
J Biomol Struct Dyn; 2023 Nov; 41(19):10037-10050. PubMed ID: 36451602
[TBL] [Abstract][Full Text] [Related]
14. Bioactive compounds from
Moharana M; Pattanayak SK; Khan F
J Biomol Struct Dyn; 2023 Dec; 41(20):10478-10494. PubMed ID: 36541128
[TBL] [Abstract][Full Text] [Related]
15. Dietary phytochemicals as potent chemotherapeutic agents against breast cancer: Inhibition of NF-κB pathway via molecular interactions in rel homology domain of its precursor protein p105.
Khan MK; Ansari IA; Khan MS
Pharmacogn Mag; 2013 Jan; 9(33):51-7. PubMed ID: 23661994
[TBL] [Abstract][Full Text] [Related]
16. Exploring the potential of phytochemicals as inhibitors of 3'-phosphoadenosine 5'-phosphosulfate synthase 1 targeting cancer therapy.
Alharbi B; Alharethi SH; Al-Soud WA; Ahmed Al-Keridis L; Aljohani AA; Jairajpuri DS; Alshammari N; Adnan M
J Biomol Struct Dyn; 2024 Apr; 42(6):3193-3203. PubMed ID: 37184152
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Potential Phytochemicals from Carica papaya Targeting BRCA-1 in Breast Cancer Treatment.
Ibrahim A; Ipinloju N; Aiyelabegan AO; Alfa-Ibrahim AA; Muhammad SA; Oyeneyin OE
Appl Biochem Biotechnol; 2023 Dec; 195(12):7159-7175. PubMed ID: 36988843
[TBL] [Abstract][Full Text] [Related]
18. Unveiling the Anti-Cancer Potential of Onoceranoid Triterpenes from
Hardianto A; Mardetia SS; Destiarani W; Budiman YP; Kurnia D; Mayanti T
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834479
[TBL] [Abstract][Full Text] [Related]
19. Dynamacophore model for breast cancer estrogen receptor alpha as an effective lead generation screening technique.
Shanmugarajan D; Biju A; Sibi D; Sibi R; Shaji M; David C
J Biomol Struct Dyn; 2023; 41(22):13029-13040. PubMed ID: 37154819
[TBL] [Abstract][Full Text] [Related]
20. Integrating biocomputational techniques for Breast cancer drug discovery via the HER-2, BCRA, VEGF and ER protein targets.
Odunitan TT; Saibu OA; Apanisile BT; Omoboyowa DA; Balogun TA; Awe AV; Ajayi TM; Olagunju GV; Mahmoud FM; Akinboade M; Adeniji CB; Abdulazeez WO
Comput Biol Med; 2024 Jan; 168():107737. PubMed ID: 38000249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
